Literature DB >> 3321964

Neurogenic heart disease: a unifying hypothesis.

M A Samuels1.   

Abstract

Electrocardiographic abnormalities have been known to occur in the context of neurologic disease for a long time. These changes fall into 2 categories: arrhythmias and repolarization abnormalities. However, until relatively recently these changes were believed to represent purely electrophysiologic alterations and not real heart disease. It is now clear that some patients with neurogenic electrocardiographic changes show cardiac enzyme release and myofibrillar degeneration at autopsy. There are 4 major methods for producing myofibrillar degeneration (i.e., contraction band necrosis or coagulative myocytolysis): catecholamine infusion, stress-steroid, nervous system stimulation and reperfusion. The common thread connecting these 4 methods is the opening of receptor-operated calcium channels, resulting in intense contraction of cardiac muscle. Thus, neurogenic influence over cardiac function may represent a continuum. In the mild reversible circumstance, only the electrocardiographic change will be seen, whereas in the severe, irreversible situation, myofibrillar degeneration will ensue with release of cardiac enzymes. Cardiac cell death may be caused by oxygen free radicals produced by metabolism of catecholamines or reperfusion or both, after variable periods of ischemia. This concept represents a unifying hypothesis, tying together the clinical, physiologic, biochemical and pathologic findings in neurogenic heart disease.

Entities:  

Mesh:

Year:  1987        PMID: 3321964     DOI: 10.1016/0002-9149(87)90678-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage.

Authors:  Avinash Kothavale; Nader M Banki; Alexander Kopelnik; Sirisha Yarlagadda; Michael T Lawton; Nerissa Ko; Wade S Smith; Barbara Drew; Elyse Foster; Jonathan G Zaroff
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 2.  Cardiopulmonary complications of brain injury.

Authors:  Alexander Grunsfeld; Jeffery J Fletcher; Barnett R Nathan
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 5.081

Review 3.  Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke.

Authors:  Poornima Venkat; Jieli Chen; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-11       Impact factor: 6.200

4.  Seizure-related takotsubo cardiomyopathy in a patient with recurrent malignant meningioma.

Authors:  Josephine Warren; Usman Baber; Bibhu Mohanty; Samin K Sharma; Annapoorna Kini; Roxana Mehran
Journal:  J Neurol       Date:  2014-11-20       Impact factor: 4.849

5.  Neurogenic pulmonary edema and other mechanisms of impaired oxygenation after aneurysmal subarachnoid hemorrhage.

Authors:  Paul M Vespa; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 6.  [Elevated troponin and ECG alterations in acute ischemic stroke and subarachnoid hemorrhage].

Authors:  T Liman; M Endres
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

7.  Elevated troponin levels are predictive of mortality in surgical intracerebral hemorrhage patients.

Authors:  Matthew C Garrett; Ricardo J Komotar; Robert M Starke; Darshan Doshi; Marc L Otten; E Sander Connolly
Journal:  Neurocrit Care       Date:  2009-07-21       Impact factor: 3.210

Review 8.  Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death.

Authors:  A M Davis; B H Natelson
Journal:  Tex Heart Inst J       Date:  1993

9.  Neurogenic Cardiac Injury.

Authors:  Nader M. Banki; Jonathan G. Zaroff
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-12

10.  B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: a prospective study in non-cardiac patients.

Authors:  Eric Meaudre; Christophe Jego; Nadia Kenane; Ambroise Montcriol; Henry Boret; Philippe Goutorbe; Gilbert Habib; Bruno Palmier
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.